HSPA5 and breast carcinoma: BiP has been described in the cell surface of breast cancer cells; however, its prognostic value remains controversial: cell surface expression was associated with good prognosis and response to chemotherapy in PR+ breast cancers [12] and triple-negative breast cancer [13,66].